These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

568 related items for PubMed ID: 20688607

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Anti-tumor mechanism of norcantharidin for the implanted tumors of human gallbladder carcinoma in nude mice in vivo].
    Fan YZ, Zhao ZM, Fu JY, Chen CQ.
    Zhonghua Wai Ke Za Zhi; 2006 May 01; 44(9):618-22. PubMed ID: 16784656
    [Abstract] [Full Text] [Related]

  • 4. [Effects of norcantharidin on angiogenesis of human gallbladder carcinoma and its anti-angiogenic mechanisms].
    Fan YZ, Chen CQ, Zhao ZM, Sun W.
    Zhonghua Yi Xue Za Zhi; 2006 Mar 14; 86(10):693-9. PubMed ID: 16681930
    [Abstract] [Full Text] [Related]

  • 5. Influence of norcantharidin on proliferation, proliferation-related gene proteins proliferating cell nuclear antigen and Ki-67 of human gallbladder carcinoma GBC-SD cells.
    Fan YZ, Fu JY, Zhao ZM, Chen CQ.
    Hepatobiliary Pancreat Dis Int; 2004 Nov 14; 3(4):603-7. PubMed ID: 15567755
    [Abstract] [Full Text] [Related]

  • 6. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
    Zhang JT, Fan YZ, Chen CQ, Zhao ZM, Sun W.
    Int J Oncol; 2012 May 14; 40(5):1501-14. PubMed ID: 22200632
    [Abstract] [Full Text] [Related]

  • 7. Norcantharidin inhibits tumor growth and vasculogenic mimicry of human gallbladder carcinomas by suppression of the PI3-K/MMPs/Ln-5γ2 signaling pathway.
    Zhang JT, Sun W, Zhang WZ, Ge CY, Liu ZY, Zhao ZM, Lu XS, Fan YZ.
    BMC Cancer; 2014 Mar 15; 14():193. PubMed ID: 24628713
    [Abstract] [Full Text] [Related]

  • 8. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
    Li XP, Jing W, Sun JJ, Liu ZY, Zhang JT, Sun W, Zhu W, Fan YZ.
    BMC Cancer; 2015 Jul 19; 15():527. PubMed ID: 26187792
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of norcantharidin's derivative Nd3 on proliferation of human ovarian cancer cell line SKOV3 and its possible mechanisms].
    Cao JH, Xu B, Li M, Wu DZ, Huang W, Cui JR.
    Ai Zheng; 2007 Apr 19; 26(4):361-6. PubMed ID: 17430652
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells.
    Mei L, Sang W, Cui K, Zhang Y, Chen F, Li X.
    Cancer Sci; 2019 Feb 19; 110(2):582-595. PubMed ID: 30520540
    [Abstract] [Full Text] [Related]

  • 19. Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells.
    Yu CC, Ko FY, Yu CS, Lin CC, Huang YP, Yang JS, Lin JP, Chung JG.
    Int J Oncol; 2012 Sep 19; 41(3):1050-60. PubMed ID: 22684608
    [Abstract] [Full Text] [Related]

  • 20. [Effects of CPUY013, a novel Topo I inhibitor, on human gastric adenocarcinoma BGC823 cells in vitro and in vivo].
    Ji YB, Zhou JH, Zuo MX, You QD.
    Yao Xue Xue Bao; 2008 Aug 19; 43(8):811-8. PubMed ID: 18956773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.